ArticleFrontiers in pharmacology2021

TPD52L2 Is a Prognostic Biomarker and Correlated With Immune Infiltration in Lung Adenocarcinoma.

Anyuan Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.